Overview
Patrice Berthezene practices practicing medicine in Marseille, France.
Her clinical expertise encompasses Cerebral Hypoxia, Pancreatic Ductal Adenocarcinoma, and Pancreatic Cancer.
She is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Patrice Berthezene
Is Patrice Berthezene a top-rated expert for Cerebral Hypoxia?
MediFind is an objective health platform that identifies experts based on real-world data. Patrice Berthezene is classified as an Experienced expert for Cerebral Hypoxia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Patrice Berthezene participate in research or clinical trials?
Yes. Patrice Berthezene has published 8 articles and abstracts on conditions like Cerebral Hypoxia. You can view a list of Patrice Berthezene's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cerebral HypoxiaMs. Berthezene isExperienced. Learn about Cerebral Hypoxia.
- Pancreatic CancerMs. Berthezene isExperienced. Learn about Pancreatic Cancer.
- Pancreatic Ductal AdenocarcinomaMs. Berthezene isExperienced. Learn about Pancreatic Ductal Adenocarcinoma.